Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Infect Control Hosp Epidemiol ; 40(3): 368-371, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30767830

RESUMO

We describe the high burden of carbapenemase-producing Enterobacteriaceae (CPE) colonization and infection in a neuro-rehabilitation hospital in Italy over a 6-year period. Overall, 9.3% of patients were found to be CPE carriers on admission; the rates of CPE in-hospital acquisition and CPE-BSI were 9.2 and 2.9 cases per 10,000 patient days, respectively.


Assuntos
Portador Sadio/transmissão , Infecções por Enterobacteriaceae/transmissão , Adulto , Enterobacteriáceas Resistentes a Carbapenêmicos , Feminino , Humanos , Incidência , Controle de Infecções/estatística & dados numéricos , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos
2.
Infect Control Hosp Epidemiol ; 38(1): 76-82, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-27745559

RESUMO

OBJECTIVE To assess the impact of an antimicrobial stewardship program (ASP) on antibiotic consumption, Clostridium difficile infections (CDI), and antimicrobial resistance patterns in a rehabilitation hospital. DESIGN Quasi-experimental study of the periods before (from January 2011 to June 2012) and after (from July 2012 to December 2014) ASP implementation. SETTING 150-bed rehabilitation hospital dedicated to patients with spinal-cord injuries. INTERVENTION Beginning in July 2012, an ASP was implemented based on systematic bedside infectious disease (ID) consultation and structural interventions (ie, revision of protocols for antibiotic prophylaxis and education focused on the appropriateness of antibiotic prescriptions). Antibiotic consumption, occurrence of CDI, and antimicrobial resistance patterns of selected microorganisms were compared between periods before and after the ASP implementation. RESULTS Antibiotic consumption decreased from 42 to 22 defined daily dose (DDD) per 100 patient days (P<.001). The main reductions involved carbapenems (from 13 to 0.4 DDD per 100 patient days; P=.01) and fluoroquinolones (from 11.8 to 0.99 DDD per 100 patient days; P=.006), with no increases in mortality or length of stay. The incidence of CDI decreased from 3.6 to 1.2 cases per 10,000 patient days (P=.001). Between 2011 and 2014, the prevalence of extensively drug-resistant (XDR) strains decreased from 55% to 12% in P. aeruginosa (P<.001) and from 96% to 73% in A. baumannii (P=.03). The prevalence of ESBL-producing strains decreased from 42% to 17% in E. coli (P=.0007) and from 62% to 15% in P. mirabilis (P=.0001). In K. pneumoniae, the prevalence of carbapenem-resistant strains decreased from 42% to 17% (P=.005), and the prevalence of in methicillin-resistant S. aureus strains decreased from 77% to 40% (P<.0008). CONCLUSIONS An ASP based on ID consultation was effective in reducing antibiotic consumption without affecting patient outcomes and in improving antimicrobial resistance patterns in a rehabilitation hospital. Infect Control Hosp Epidemiol. 2016;1-7.


Assuntos
Antibioticoprofilaxia , Gestão de Antimicrobianos/métodos , Infecção Hospitalar/prevenção & controle , Infecções por Bactérias Gram-Negativas/epidemiologia , Infecções por Bactérias Gram-Negativas/prevenção & controle , Centros de Reabilitação/organização & administração , Antibacterianos/administração & dosagem , Carbapenêmicos/administração & dosagem , Fluoroquinolonas/administração & dosagem , Mortalidade Hospitalar/tendências , Humanos , Itália , Encaminhamento e Consulta , Traumatismos da Coluna Vertebral/reabilitação
3.
APMIS ; 124(6): 516-21, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27004836

RESUMO

Enterobacter aerogenes has recently emerged as an important hospital pathogen. In this study, we showed the emergence of E. aerogenes isolates carrying the blaKPC gene in patients colonized by carbapenem-resistant Klebsiella pneumoniae strains. Two multiresistant E. aerogenes isolates were recovered from bronchial aspirates of two patients hospitalized in the Intensive Care Unit at the "Santa Maria della Scaletta" Hospital, Imola. The antimicrobial susceptibility test showed the high resistance to carbapenems and double-disk synergy test confirmed the phenotype of KPC and AmpC production. Other investigation revealed that ESBL and blaKPC genes were carried on the conjugative pKpQIL plasmid. This is a relevant report in Italy that describes a nosocomial infection due to the production of KPC beta-lactamases by an E. aerogenes isolate in patients previously colonized by K. pneumoniae carbapenem-resistant. In conclusion, it's necessary a continuous monitoring of multidrug-resistant strains for the detection of any KPC-producing bacteria that could expand the circulation of carbapenem-resistant pathogens.


Assuntos
Proteínas de Bactérias/genética , Infecção Hospitalar/microbiologia , Enterobacter aerogenes/enzimologia , Enterobacter aerogenes/isolamento & purificação , Infecções por Enterobacteriaceae/microbiologia , Unidades de Terapia Intensiva , beta-Lactamases/genética , Antibacterianos/farmacologia , Brônquios/microbiologia , DNA Bacteriano/química , DNA Bacteriano/genética , Farmacorresistência Bacteriana Múltipla , Enterobacter aerogenes/efeitos dos fármacos , Enterobacter aerogenes/genética , Hospitais , Humanos , Itália , Klebsiella pneumoniae/isolamento & purificação , Testes de Sensibilidade Microbiana , Plasmídeos/análise , Análise de Sequência de DNA
4.
New Microbiol ; 38(4): 589-92, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26485019

RESUMO

Invasive Group A Streptococcus disease is a severe and sometimes life-threatening infection with only few cases reported in literature. We describe the case of a 49-day-old male infant with invasive Group A Streptococcus infection characterized by acute otitis media and development of septicemia within a probably community-acquired cluster. The causative agent resulted to be a rare emm-89 genotype of Streptococcus pyogenes. Group A Streptococcus must be considered responsible for sepsis in newborns and young infants.


Assuntos
Infecções Comunitárias Adquiridas/microbiologia , Sepse/microbiologia , Infecções Estreptocócicas/microbiologia , Streptococcus pyogenes/isolamento & purificação , Genótipo , Humanos , Lactente , Masculino , Streptococcus pyogenes/genética
5.
Indian J Microbiol ; 55(3): 345-8, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26063946

RESUMO

Chlamydophila pneumoniae is a pathogenic agent, involved in various types of infection. This study has evaluated the ability of IgG antibodies in outpatient, with acute respiratory tract infections from C. pneumoniae, to neutralize in vitro purified elementary bodies of this bacterium, revealing a good neutralizing performance of IgG antibodies.

7.
Indian J Pathol Microbiol ; 58(1): 45-7, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25673591

RESUMO

BACKGROUND: Group B Streptococcus (GBS) is an important pathogen that causes serious infections in newborns. Pregnant screening and intrapartum antibiotic prophylaxis are actually the strategies to prevent GBS disease in neonates because vaccination is under investigation. MATERIALS AND METHODS: Simultaneously, 156 isolates of GBS and 156 isolates other than GBS covering 17 different species, were tested to evaluate the selectivity of a new chromogenic medium to screen GBS. RESULTS: The new new chromogenic medium showed an excellent performance, exhibiting a very high level of inclusivity (100%) and exclusivity (96.1%).


Assuntos
Técnicas Bacteriológicas/métodos , Meios de Cultura/química , Infecções Estreptocócicas/diagnóstico , Streptococcus agalactiae/isolamento & purificação , Compostos Cromogênicos/metabolismo , Feminino , Humanos , Lactente , Recém-Nascido , Gravidez , Infecções Estreptocócicas/microbiologia
8.
APMIS ; 122(6): 552-5, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24106832

RESUMO

Ureaplasma urealyticum is an opportunistic pathogen during pregnancy and in newborns. Other clinical problems related to U. urealyticum infections are: no susceptibility to cell wall-active drugs, limits of antibiotic treatment in pregnancy, and spread of antimicrobial resistance. In addition, the results of antimicrobial susceptibility against U. urealyticum from various countries are few and controversial. The antimicrobial susceptibility of U. urealyticum, isolated from cervical swabs and collected from outpatient childbearing-aged women in Italy from 2009 to 2012, was performed against fluoroquinolones, macrolides, streptogramin and tetracyclines, using an available biochemical commercial kit and a specific solid culture medium, to improve the therapeutic management of these pathogenic agents. Ureaplasma urealyticum was detected in 49.4% of samples, but significant bacterial load was revealed in 29.8%. In vitro tetracyclines showed the best activity against U. urealyticum, followed by streptogramin, macrolides, and fluoroquinolones.


Assuntos
Infecções por Ureaplasma/tratamento farmacológico , Infecções por Ureaplasma/microbiologia , Ureaplasma urealyticum/efeitos dos fármacos , Ureaplasma urealyticum/isolamento & purificação , Cervicite Uterina/tratamento farmacológico , Cervicite Uterina/microbiologia , Adolescente , Adulto , Antibacterianos/farmacologia , Carga Bacteriana , Colo do Útero/microbiologia , Feminino , Humanos , Recém-Nascido , Itália , Testes de Sensibilidade Microbiana , Infecções Oportunistas/complicações , Infecções Oportunistas/tratamento farmacológico , Infecções Oportunistas/microbiologia , Gravidez , Complicações Infecciosas na Gravidez/tratamento farmacológico , Complicações Infecciosas na Gravidez/microbiologia , Tetraciclinas/farmacologia , Infecções por Ureaplasma/complicações , Ureaplasma urealyticum/patogenicidade , Cervicite Uterina/complicações , Adulto Jovem
9.
Indian J Pathol Microbiol ; 54(4): 786-9, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22234111

RESUMO

BACKGROUND: Toxoplasma gondii infection, common parasitic zoonoses, is an important cause of spontaneous abortion, mental retardation, encephalitis, ocular disease and death worldwide. Today the major diagnostic techniques for the toxoplasmosis are serological assays, but its have many limitations. AIM: The goal in this study is to improve the diagnostic accuracy of T. gondii infection, using direct (Real Time PCR) and indirect (IgM, IgA, IgG and IgG avidity) diagnostic techniques. MATERIALS AND METHODS: In the period between 2007 and 2008, 96 non consecutive different clinical samples (38 blood, 40 amniotic fluids, 8 cerebrospinal fluids, 10 vitreous humors) and 96 sera have been studied simultaneously through molecular biology and serological techniques. RESULTS: Direct and indirect diagnostic techniques used in this study for laboratory diagnosis of T. gondii infection were always concordant. CONCLUSIONS: The high correlation between direct and indirect diagnostic techniques exhibit that serologic techniques are accurate diagnostic assays as screening test in laboratory diagnosis of toxoplasmosis.


Assuntos
Técnicas de Laboratório Clínico/métodos , Toxoplasma/genética , Toxoplasma/imunologia , Toxoplasmose/diagnóstico , Anticorpos Antiprotozoários/sangue , Afinidade de Anticorpos , Feminino , Humanos , Imunoensaio/métodos , Técnicas de Diagnóstico Molecular/métodos , Gravidez , Reação em Cadeia da Polimerase em Tempo Real/métodos
10.
Vet Microbiol ; 123(1-3): 269-73, 2007 Jul 20.
Artigo em Inglês | MEDLINE | ID: mdl-17391870

RESUMO

Nine Chlamydia suis isolates, obtained from pigs with conjunctivitis, were molecularly characterized by ompA sequencing and their in vitro susceptibility to six cathelicidin peptides (SMAP-29, BAC-7, BMAP-27, BMAP-27, BMAP-28, PG-1, LL-37) determined in cell culture. SMAP-29 was the most active peptide, reducing the intracellular inclusion number by > or =50% at a concentration of 10 microg/ml (3 microM) in six of the nine isolates tested. Three molecularly identical isolates were insensitive at a concentration as high as 80 microg/ml (25 microM). Of the remaining cathelicidin peptides tested, BAC-7 and BMAP-27 were active against six C. suis isolates at a concentration of 80 microg/ml (25 and 26 microM, respectively). Cathelicidins LL-37 and PG-1 did not show any anti-chlamydial activity at 80 microg/ml.


Assuntos
Antibacterianos/farmacologia , Peptídeos Catiônicos Antimicrobianos/farmacologia , Chlamydia/classificação , Chlamydia/efeitos dos fármacos , Sequência de Aminoácidos , Animais , Antibacterianos/química , Peptídeos Catiônicos Antimicrobianos/química , Catelicidinas , Bovinos , Linhagem Celular , Chlorocebus aethiops , Humanos , Suínos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...